Pittler S J, Kozak L P, Wilson J E
Biochim Biophys Acta. 1985 Dec 13;843(3):186-92. doi: 10.1016/0304-4165(85)90138-2.
Hexokinase (ATP:D-hexose 6-phosphotransferase, EC 2.7.1.1) has been synthesized in the rabbit reticulocyte lysate system directed by poly(A)+ mRNA isolated from rat brain. Identification of the in vitro synthesis product as hexokinase was based on its immunoprecipitation with anti-hexokinase serum as well as the generation of identical peptide maps after partial cleavage of the in vitro product and authentic hexokinase with Staphylococcus aureus V8 proteinase or chymotrypsin. The in vitro product and authentic hexokinase were indistinguishable in molecular weight (SDS-gel electrophoresis); thus, despite the fact that, in situ, much of the hexokinase in brain is found in association with mitochondria, it is not synthesized in the form of a higher molecular weight precursor as is characteristic of other mitochondrial proteins. This is in accord with the view that hexokinase is best considered as a classical 'soluble' enzyme which is capable of exhibiting reversible association with mitochondria. The in vitro product cochromatographs (during anion-exchange HPLC) with authentic hexokinase previously shown to have a blocked (presumably acetylated) N-terminus; this procedure is capable of resolving the N-terminally blocked form of the enzyme from a partially proteolyzed form having a free N-terminal amino group. Thus the in vitro product is apparently N-acetylated by an enzyme system previously shown to be present in reticulocyte lysates. A significant fraction of the in vitro synthesized hexokinase attained a conformation characteristic of the native enzyme as judged by the observations that it could be immunoprecipitated by monoclonal antibodies recognizing the native enzyme but not by antibodies recognizing denatured hexokinase, and limited tryptic cleavage of the in vitro product gave fragments identical to those seen with the native enzyme and thought to reflect the organization of structural domains in that enzyme. However, based on these same criteria, the majority of the hexokinase synthesized in vitro appears to exist in a folding state that is not identical to that of either the fully denatured or native enzyme.
己糖激酶(ATP:D - 己糖6 - 磷酸转移酶,EC 2.7.1.1)已在兔网织红细胞裂解物系统中由从大鼠脑分离的聚腺苷酸加尾mRNA指导合成。体外合成产物被鉴定为己糖激酶,这是基于其与抗己糖激酶血清的免疫沉淀,以及在体外产物和天然己糖激酶用金黄色葡萄球菌V8蛋白酶或胰凝乳蛋白酶部分切割后产生相同的肽图。体外产物和天然己糖激酶在分子量上无法区分(SDS - 凝胶电泳);因此,尽管事实上在脑内原位发现的大部分己糖激酶与线粒体相关,但它并非像其他线粒体蛋白那样以高分子量前体的形式合成。这与以下观点一致,即己糖激酶最好被视为一种经典的“可溶性”酶,它能够与线粒体呈现可逆结合。体外产物与先前显示具有封闭(可能是乙酰化)N末端的天然己糖激酶在阴离子交换高效液相色谱过程中共色谱;该方法能够将酶的N末端封闭形式与具有游离N末端氨基的部分蛋白水解形式区分开来。因此,体外产物显然被先前显示存在于网织红细胞裂解物中的酶系统进行了N - 乙酰化。通过以下观察判断,体外合成的己糖激酶中有很大一部分获得了天然酶的构象特征:它可以被识别天然酶的单克隆抗体免疫沉淀,但不能被识别变性己糖激酶的抗体免疫沉淀,并且体外产物的有限胰蛋白酶切割产生的片段与天然酶的片段相同,并且被认为反映了该酶中结构域的组织方式。然而,基于这些相同标准,体外合成的大部分己糖激酶似乎以一种折叠状态存在,这种状态与完全变性或天然酶的折叠状态都不相同。